BUY Glenmark Pharmaceuticals — Akshay Bhagwat, JM Financial
byAkshay Bhagwat, JM FinancialHorizon: NA (inferred Swing (≤2wk))23 Apr 2026via ET Now
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
1 other SEBI-registered advisor has an active swing BUY call on this stock, issued in the last 14 days
Advisor consensus · same horizon·5 May · 3d ago
Nothing found in this tip’s window yet.
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Glenmark Pharmaceuticals
- BUY — Prakash Gaba21 Oct 2026 · Same day · target ₹2,300 · SL hit
- BUY — Somil Mehta, Sharekhan19 Oct 2026 · ~2 weeks · target ₹2,400 · SL hit
- BUY — Osho Krishan, Angel One13 Oct 2026 · ~2 weeks · target ₹2,400 · Active
- BUY — Manas Jaiswal9 Oct 2026 · ~2 weeks · target ₹2,375 · SL hit
- BUY — Prakash Gaba9 Oct 2026 · ~2 weeks · target ₹2,350 · SL hit
More from Akshay Bhagwat, JM Financial
- BUY The Indian Hotels Company23 Oct 2026 · ~2 weeks · target ₹800 · Active
- BUY Bharti Airtel23 Oct 2026 · ~2 weeks · target ₹1,950 · Active
- SELL Tata Steel22 Oct 2026 · ~2 weeks · target ₹163 · Active
- BUY Bharti Airtel22 Oct 2026 · ~2 weeks · target ₹1,980 · Active
- BUY Samvardhana Motherson International21 Oct 2026 · ~2 weeks · target ₹164 · SL hit

